Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

<strong>Background<br></strong> Late treatment failures after artemisinin-based combination therapies (ACTs) for falciparum malaria have increased in the Greater Mekong subregion in southeast Asia. Addition of amodiaquine to artemether–lumefantrine could provide an efficacious trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Peto, TJ, Tripura, R, Callery, JJ, Lek, D, Nghia, HDT, Nguon, C, Thuong, NTH, van der Pluijm, RW, Dung, NTP, Sokha, M, Luong, VV, Long, LT, Sovann, Y, Duanguppama, J, Waithira, N, Hoglund, RM, Chotsiri, P, Chau, NH, Ruecker, A, Amaratunga, C, Dhorda, M, Miotto, O, Maude, RJ, Rekol, H, Chotivanich, K, Tarning, J, von Seidlein, L, Imwong, M, Mukaka, M, Day, NPJ, Hien, TT, White, NJ, Dondorp, AM
Formato: Journal article
Lenguaje:English
Publicado: Elsevier 2022

Ejemplares similares